FPS
ANIK icon

Fieldpoint Private Securities’s Anika Therapeutics ANIK Stock Holding History

Fieldpoint Private Securities’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5
Closed – – 1652
2021
Q4 		$0 Sell
5
-30
-86% -$1.2K ﹤0.01% 1642
2021
Q3 		$1K Hold
35
– – ﹤0.01% 1533
2021
Q2 		$1K Hold
35
– – ﹤0.01% 1436
2021
Q1 		$1K Hold
35
– – ﹤0.01% 1433
2020
Q4 		$2K Buy
+35
New +$1.33K ﹤0.01% 1292

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Fieldpoint Private Securities's ANIK Position: Q1 2022 in Review

Fieldpoint Private Securities sold out of Anika Therapeutics (ANIK) in Q1 2022, closing a stake of 5 shares.

Fieldpoint Private Securities first reported a position in ANIK in Q4 2020 and held it in 5 quarters. The position peaked at $2K in Q4 2020. 118 funds tracked by Wall St. Rank hold ANIK as of Q1 2022.

  • Fieldpoint Private Securities reported no remaining Anika Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Fieldpoint Private Securities sold 5 Anika Therapeutics shares in Q1 2022.
  • Fieldpoint Private Securities first reported a position in Anika Therapeutics in Q4 2020 and held it in 5 quarters.
  • Fieldpoint Private Securities's Anika Therapeutics position peaked at $2K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2022.

Based on Fieldpoint Private Securities's 13F filing for Q1 2022, filed 7 Apr 2022.